Literature DB >> 7091262

Epiretinal membrane formation after vitrectomy.

W H Stern, S K Fisher, D H Anderson, J J O'Donnell, P A Erickson, G P Lewis, C J Guerin, G A Borgula, M A McDermott.   

Abstract

Our experimental model of epiretinal membrane formation in the rabbit eye after lensectomy and vitrectomy provides a way of studying pharmacologic and surgical approaches to inhibiting epiretinal cellular proliferation and contraction in the eye that has undergone vitrectomy. We injected 400,000 tissue-cultured retinal pigment epithelial cells onto the retinal surface of rabbit eyes that had undergone lensectomy, vitrectomy, and fluid-gas exchange. By one week, a funnel-shaped detachment of the medullary rays had occurred in 100% of the injected eyes. Histologically, the cells formed an epiretinal membrane by six hours after injection and caused major wrinkling of the inner retina after 24 to 48 hours. The percentage of tritiated-thymidine-labeled epiretinal cells increased dramatically 24 hours after injection and then declined. Cellular membranes bridging the optic nerve, followed by growth and contraction of the epiretinal cells on the detached internal limiting membrane, were responsible for the closed funnel appearance of the medullary rays.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091262     DOI: 10.1016/0002-9394(82)90472-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Improvement of horizontal macular contraction after surgical removal of epiretinal membranes.

Authors:  H K Yang; S J Kim; Y S Jung; K G Kim; J H Kim; H G Yu
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

3.  Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.

Authors:  J Baldinger; B H Doft; S A Burns; B Johnson
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

4.  Nd-YAG laser treatment in preretinal macular fibrosis.

Authors:  M J Tassignon; M Brihaye; N Stempels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.

Authors:  T Hida; D B Chandler; S M Sheta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

6.  Unexpected traction retinal detachment: a complication of an animal model of pars plana vitrectomy.

Authors:  W A van der Zee; J S Lean; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

7.  The effects of injections of cultured fibroblasts into the rabbit vitreous.

Authors:  C A Hitchins; I Grierson; P S Hiscott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

8.  Temporary use of silicone oil in the treatment of proliferative vitreoretinopathy. An experimental study with a new animal model.

Authors:  M Gonvers; R Thresher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

9.  Experimental posterior perforating ocular injury: a controlled study of the gross effects of localised gamma irradiation.

Authors:  U Chakravarthy; C J Maguire; D B Archer
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

10.  Regular silicone and fluorosilicone oil in the prevention of retinal detachment caused by experimental proliferative vitreoretinopathy.

Authors:  A Alghadyan; G A Peyman; C Fizer; M Tawakol; K R Liu; B Yue; J H Peace
Journal:  Int Ophthalmol       Date:  1988-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.